234 related articles for article (PubMed ID: 7954867)
1. Diagnosis and monitoring of amyloidosis.
Hawkins PN
Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
[TBL] [Abstract][Full Text] [Related]
2. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
3. Amyloidosis.
Hawkins PN
Blood Rev; 1995 Jun; 9(2):135-42. PubMed ID: 7580390
[TBL] [Abstract][Full Text] [Related]
4. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
Maulin L; Hachulla E; Deveaux M; Janin A; Wechsler B; Godeau P; Rousset H; Barrier JH; Hatron PY; Devulder B; Huglo D; Marchandise X
QJM; 1997 Jan; 90(1):45-50. PubMed ID: 9093588
[TBL] [Abstract][Full Text] [Related]
5. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.
Hawkins PN
Clin Sci (Lond); 1994 Sep; 87(3):289-95. PubMed ID: 7955904
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.
Hawkins PN; Richardson S; Vigushin DM; David J; Kelsey CR; Gray RE; Hall MA; Woo P; Lavender JP; Pepys MB
Arthritis Rheum; 1993 Jun; 36(6):842-51. PubMed ID: 8507227
[TBL] [Abstract][Full Text] [Related]
7. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X
Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
Hawkins PN; Lavender JP; Pepys MB
N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176
[TBL] [Abstract][Full Text] [Related]
11. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN
Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172
[TBL] [Abstract][Full Text] [Related]
12. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract.
Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
Hawkins PN; Richardson S; MacSweeney JE; King AD; Vigushin DM; Lavender JP; Pepys MB
Q J Med; 1993 Jun; 86(6):365-74. PubMed ID: 8171184
[TBL] [Abstract][Full Text] [Related]
14. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
[TBL] [Abstract][Full Text] [Related]
15. Imaging in systemic amyloidosis.
Sachchithanantham S; Wechalekar AD
Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
Hawkins PN
Curr Opin Nephrol Hypertens; 2002 Nov; 11(6):649-55. PubMed ID: 12394612
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
Pepys MB
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic tools for amyloidosis.
Hachulla E; Grateau G
Joint Bone Spine; 2002 Dec; 69(6):538-45. PubMed ID: 12537260
[TBL] [Abstract][Full Text] [Related]
19. Treatment of amyloidosis.
Tan SY; Pepys MB; Hawkins PN
Am J Kidney Dis; 1995 Aug; 26(2):267-85. PubMed ID: 7645531
[TBL] [Abstract][Full Text] [Related]
20. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
Wall JS; Kennel SJ; Paulus MJ; Gleason S; Gregor J; Baba J; Schell M; Richey T; O'Nuallain B; Donnell R; Hawkins PN; Weiss DT; Solomon A
Amyloid; 2005 Sep; 12(3):149-56. PubMed ID: 16194869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
